Approval · Notice of Compliance 7637 · 2005
UROMAX: Notice of Compliance 7637
Issued December 1, 2005
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 7637
- Date
- December 1, 2005
- Company
- Purdue PharmaToronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Therapeutic class
- Anticholinergique, antispasmodic
Products in this notice
Medicinal ingredients
- OXYBUTYNIN CHLORIDE 10 MG per TAB
- OXYBUTYNIN CHLORIDE 15 MG per TAB